Biotech Operations Scaling 
LSA Global
FEBRUARY 6, 2023
The team needs to scale to meet new and future challenges and be able to support a strong, integrated, and collaborative matrix operating model. The post LSA Global Delivers Facilitative Leadership Workshop for Biotech Company appeared first on LSA Global. Learn more about getting aligned.
Chief Executive
JUNE 7, 2022
We were a company without any history of commercial operations,” David Meline told the recent CFO Leadership Council’s 12th Annual CFO Leadership Conference in Boston. “We We were scaling the company at the same time we were bringing product to market, and we went through a cycle continuously where we were shifting from one to the other.”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Chief Executive
OCTOBER 31, 2022
Overall, the larger the company (by annual revenues), the more likely it is to invest in automation to curb the impact of wage increases, particularly when it comes to back-office operations. Here, too, size plays a role, but this time, the peer groups at both ends of the scale show an advantage.
Chief Executive
SEPTEMBER 12, 2022
The CEO of a biotech company participating in the poll said his forecast for improving conditions was rooted in “optimism that supply chain issues resolve, Ukraine/Russia war is resolved and business across the globe improves, and inflation is moderated without spiking interest rates too high from here,” he said.
Mike Griffiths
FEBRUARY 18, 2021
The company was formed by two boat-building partners who honed their specialization (boat designs), hire a skilled workforce, and operate from an office in the marina. Being web-based and having access to a diverse workforce allows for relatively easy-to-run small-scale experiments. Going Online.
LSA Global
MARCH 1, 2021
For example, one of our Biotech clients focuses exclusively on ultra-rare diseases, one of our high tech clients concentrates solely on the Fortune 500 on the West Coast, and one of our services clients centers their organization entirely around companies that are a “hot mess.” Do We Offer Unmatched Scale?
Kotter Inc.
OCTOBER 20, 2022
The COVID-19 pandemic created significant supply chain challenges as manufacturers and distribution channels shut down, pivoted, or significantly scaled back to fight the spread of the virus. Both Anders and Chris have life-long careers in the Pharma industry, holding senior roles in both Big Pharma and smaller biotech companies.
Expert insights. Personalized for you.
36 
Let's personalize your content